glp-1 for diabetes Glucagon-like peptide-1 GLP-1 Medications for Type 1

Large employer health benefit plans increasingly include GLP-1 medications in formularies, though typically with prior authorization requirements and step therapy protocols

Severe gastrointestinal disease, particularly gastroparesis, may alter both efficacy and tolerability and requires careful consideration

Treating obesity with behavior change, generic anti-obesity medications, and GLP-1 seems to reduce the risk profile associated with all of these [cardiometabolic] diseases, Frank added

Some products are refrigerated until use

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications approved by the FDA for treating type 2 diabetes and, in some formulations, for chronic weight management

Available at: [Google Scholar] 102